Publications by authors named "Adam Velenosi"

Over the past few decades, tremendous advances have been made in our understanding of the biological changes underpinning the devastating impairment of traumatic spinal cord injury (SCI). Much of this scientific research has focused on animal models of SCI, and comparatively little has been done in human SCI, largely because biospecimens from human SCI patients are not readily available. This paucity of scientific enquiry in human SCI represents an important void in the spectrum of translational research, as biological differences between animal models and the human condition need to be considered in the pre-clinical development of therapeutic approaches.

View Article and Find Full Text PDF
Article Synopsis
  • Axonal regeneration in the mature central nervous system (CNS) is hindered by various extracellular factors, even in genetically modified mice that lack key myelin-associated inhibitors.
  • Researchers discovered high levels of histone H3 in human cerebrospinal fluid and at injury sites in animal models, indicating it acts as an inhibitor of nerve regeneration.
  • Histones inhibit nerve growth by targeting specific receptors and pathways, but this effect can be reversed with activated protein C, which enhances axonal regeneration in damaged nerves.
View Article and Find Full Text PDF

Biobank participation of children is an ethically complicated process as the vulnerability of this population is a concern throughout the entire process of biobanking. Some ethical issues are more prominent in pediatric biobanking and may not need to be considered in biobanking of adult specimens and data. These include assent, reconsent at the age of majority, capacity to consent, and consequences of genetic results on the child and family members.

View Article and Find Full Text PDF

Several retrospective studies in children with B cell precursor (BCP) acute lymphoblastic leukemia (ALL) provided clinical evidence that higher absolute lymphocyte counts (ALC) early into treatment significantly correlated with improved relapse-free and overall survival. It still remains unknown, however, whether the predictive role of higher ALCs reflects general bone marrow recovery or a more specific attribute of immune function. To investigate this question, we implemented a prospective observational cohort study in 20 children with BCP ALL on day 29 (D29) of induction chemotherapy and immunophenotyped their lymphoid (T, B and natural killer cells) and myeloid (neutrophils, monocytes, dendritic cells) compartments.

View Article and Find Full Text PDF